Scarica l'app Stockscreener
1.95
1.56%
0.03
Traws Pharma Inc Borsa (TRAW) Ultime notizie
Aug EndMonth: Will RSVR outperform tech stocks2025 Key Lessons & Safe Swing Trade Setups - baoquankhu1.vn
Published on: 2026-02-03 21:55:07 - baoquankhu1.vn
Experimental COVID Pill Shows Edge Over Paxlovid as Traws Hits Key Milestones - MyChesCo
LADENBURG THALM/SH SH Upgrades Traws Pharma (NASDAQ:TRAW) to Strong-Buy - Defense World
TRAW stock slides in volatile session – what’s the latest on its phase 2 trial for COVID-19 treatment? - MSN
Traws completes enrollment in phase 2 COVID-19 drug study By Investing.com - Investing.com Canada
Traws Pharma stock soars after completing COVID-19 treatment study By Investing.com - Investing.com South Africa
Traws Pharma stock soars after completing COVID-19 treatment study - Investing.com
TRAW Stock Slides In Volatile Session – What’s The Latest On Its Phase 2 Trial For COVID-19 Treatment? - Stocktwits
Traws Pharma (TRAW) Completes Enrollment in Phase 2 COVID-19 Stu - GuruFocus
Traws Pharma Completes Phase 2 Enrollment for COVID Candidate - TipRanks
Traws completes enrollment in phase 2 COVID-19 drug study - Investing.com
COVID drug tested in Paxlovid-ineligible patients as monthly flu pill advances - stocktitan.net
Traws targets stockpile nod as COVID drug outperforms Paxlovid in trial - MSN
Wall Street Recap: Can Traws Pharma Inc outperform under higher oil prices2025 Trade Ideas & Safe Capital Growth Stock Tips - baoquankhu1.vn
Traws Pharma’s TRX-100 Phase 1 Completion: A Quiet but Key Milestone for Investors - TipRanks
Traws Targets Stockpile Nod as COVID Drug Outperforms Paxlovid in Trial - MyChesCo
Can Traws Pharma Inc. grow without dilutionOptions Play & Advanced Swing Trade Entry Alerts - bollywoodhelpline.com
Published on: 2026-01-17 06:20:37 - baoquankhu1.vn
Traws Pharma files IND for influenza treatment, updates COVID drug trial - Investing.com Nigeria
Breakout Zone: How Traws Pharma Inc stock compares to market leadersPrice Action & Risk Controlled Swing Alerts - Bộ Nội Vụ
Traws Pharma files IND for influenza treatment, updates COVID drug trial By Investing.com - Investing.com India
Traws Pharma advances flu and COVID-19 antiviral pipeline - TipRanks
Traws Pharma Files IND for Tivoxavir Marboxil and Updates Ratutrelvir Study - TradingView
Traws Pharma Files Tivoxavir Marboxil Investigational New Drug (IND) Application for Influenza Therapy, and Provides Updated Results from the Ongoing Clinical Study of Ratutrelvir in PAXLOVID®-Eligible and Ineligible COVID-19 Patients - GlobeNewswire
COVID pill shows faster recovery, fewer side effects than Paxlovid - Stock Titan
Published on: 2026-01-11 07:18:09 - ulpravda.ru
New COVID pill shows promise against Paxlovid in early head-to-head trial - MSN
Fed Meeting: Is Traws Pharma Inc. stock a buy before product launches2025 Market WrapUp & Weekly Market Pulse Updates - Улправда
How resilient is Traws Pharma Inc. stock in market downturnsTrade Exit Report & Short-Term Trading Alerts - Улправда
Why Traws Pharma Inc. stock remains on watchlists2025 Market Outlook & Consistent Profit Trade Alerts - ulpravda.ru
Is Traws Pharma Inc. stock cheap at current valuationMarket Activity Report & Community Trade Idea Sharing - Улправда
How Traws Pharma Inc. stock compares to industry benchmarksPortfolio Risk Report & High Accuracy Trade Signal Alerts - Улправда
Traws Pharma, Inc. (NASDAQ:TRAW) Q2 2025 Earnings Call Transcript - MSN
Comparing Miravant Medical Technologies (OTCMKTS:MRVT) and Traws Pharma (NASDAQ:TRAW) - Defense World
Traws Pharma Pushes Ahead on COVID and Flu Antivirals as Costs Fall and Pipeline Advances - MSN
Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors - Moscow-Pullman Daily News
Traws Pharma (NASDAQ:TRAW) Shares Down 3.5% – Time to Sell? - Defense World
How Traws Pharma Inc. stock compares to growth peersTechnical Resistance Breaks & Fast Growing Capital Gains - bollywoodhelpline.com
CLARKE TRAFFORD Insider Trades - Nasdaq
Why Traws Pharma Inc. (0T20) stock stays on top picksAnalyst Upgrades & Master Stock Selection - Bollywood Helpline
New COVID Pill Shows Promise Against Paxlovid in Early Head-to-Head Trial - MyChesCo
Life sciences leader behind a $900M pharma sale joins cancer firm - Stock Titan
Is Traws Pharma Inc a good long term investmentRetail Trading Trends & High Return Wealth Building - earlytimes.in
Momentum Shift: Will Traws Pharma Inc. (0T20) stock benefit from mergersMarket Sentiment Report & Real-Time Buy Zone Alerts - Улправда
Traws Pharma Begins Phase 2 Trial of Ritonavir-Free COVID-19 Treatment Ratutrelvir - MSN
How Traws Pharma Inc. stock performs during Fed tightening cyclesJuly 2025 Trade Ideas & Step-by-Step Swing Trade Plans - Улправда
How Traws Pharma Inc. stock reacts to global recession fears2025 Growth vs Value & AI Driven Stock Reports - Улправда
Why Traws Pharma Inc. (0T20) stock stays on buy lists2025 Biggest Moves & Consistent Profit Trading Strategies - DonanımHaber
Aug Momentum: How Traws Pharma Inc. stock reacts to global recession fearsWeekly Investment Recap & Free Technical Confirmation Trade Alerts - Улправда
0.04%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):